CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | Aryeh Jason Director | Purchase | +202 | $112.51 | $23K | 51,594 |
| 2019-03-13 | HIGGINS JOHN L Chief Executive Officer | Purchase | +2,500 | $114.29 | $286K | 141,399 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −354 | $120.86 | $43K | 16,115 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −377 | $120.86 | $46K | 15,738 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −435 | $120.86 | $53K | 15,303 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −938 | $120.86 | $113K | 124,615 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,246 | $120.86 | $151K | 123,369 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −642 | $120.86 | $78K | 122,727 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,918 | $120.86 | $232K | 136,981 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,689 | $120.86 | $204K | 135,292 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,310 | $120.86 | $158K | 133,982 |
| 2019-02-11 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Grant or award | +6,404 | 16,469 | ||
| 2019-02-11 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Grant or award · Employee Stock Option (right to buy) | +29,298 | 29,298 | ||
| 2019-02-11 | FOEHR MATTHEW W President and COO | Grant or award | +7,472 | 125,553 | ||
| 2019-02-11 | FOEHR MATTHEW W President and COO | Grant or award · Employee Stock Option (right to buy) | +34,181 | 34,181 | ||
| 2019-02-11 | HIGGINS JOHN L Chief Executive Officer | Grant or award | +12,809 | 138,899 | ||
| 2019-02-11 | HIGGINS JOHN L Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +58,596 | 58,596 | ||
| 2019-02-11 | Berkman Charles S SVP, Gen. Counsel & Secretary | Grant or award | +3,202 | 45,897 | ||
| 2019-02-11 | Berkman Charles S SVP, Gen. Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +14,649 | 14,649 | ||
| 2019-01-23 | Berkman Charles S SVP, Gen. Counsel & Secretary | Grant or award | +1,370 | 41,283 |
Page 45 of 55 · 1,097 trades